Literature DB >> 22948978

An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans.

Andy C Dean1, Stephanie M Groman, Angelica M Morales, Edythe D London.   

Abstract

Methamphetamine (MA) is one of the most commonly abused illicit substances worldwide. Among other problems, abuse of the drug has been associated with reduced cognitive function across several domains. However, much of the literature has not attempted to differentiate cognitive difficulties caused by MA abuse from preexisting cognitive difficulties that are likely caused by other factors. Here, we address this question, evaluating evidence for a priori hypotheses pertaining to six lines of research: (a) animal studies; (b) cross-sectional human studies; (c) a twin study; (d) studies of changes in cognition with abstinence from MA; (e) studies of changes in brain structure and function with abstinence from MA; and (f) studies of the relationship between the severity of MA abuse and the extent of cognitive deficits observed. Overall the findings were mixed, with some support for a causal relationship between MA abuse and cognitive decline, and other findings suggesting that there is no relationship. The preponderance of the data, however, does support the possibility that MA abuse causes cognitive decline, of unknown duration, in at least some users of the drug. When averaged across individuals, this decline is likely to be mild in early-to-middle adulthood. However, moderator variables are likely to contribute to the presence and/or severity of cognitive decline exhibited by a given individual.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22948978      PMCID: PMC3527116          DOI: 10.1038/npp.2012.179

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  118 in total

Review 1.  What is cognitive reserve? Theory and research application of the reserve concept.

Authors:  Yaakov Stern
Journal:  J Int Neuropsychol Soc       Date:  2002-03       Impact factor: 2.892

2.  A comparison of patterns of methamphetamine and cocaine use.

Authors:  Sara L Simon; Kimberly Richardson; Jennifer Dacey; Susan Glynn; Catherine P Domier; Richard A Rawson; Walter Ling
Journal:  J Addict Dis       Date:  2002

3.  A twin study of the neuropsychological consequences of stimulant abuse.

Authors:  Rosemary Toomey; Michael J Lyons; Seth A Eisen; Hong Xian; Sunanta Chantarujikapong; Larry J Seidman; Stephen V Faraone; Ming T Tsuang
Journal:  Arch Gen Psychiatry       Date:  2003-03

4.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

5.  Overdose of 2.3 grams of intravenous methamphetamine: case, analysis and patient perspective.

Authors:  J C Buffum; A T Shulgin
Journal:  J Psychoactive Drugs       Date:  2001 Oct-Dec

6.  Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.

Authors:  D E Chapman; G R Hanson; R P Kesner; K A Keefe
Journal:  J Pharmacol Exp Ther       Date:  2001-02       Impact factor: 4.030

7.  Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users.

Authors:  Linda Chang; Thomas Ernst; Oliver Speck; Hetal Patel; Menaka DeSilva; Maria Leonido-Yee; Eric N Miller
Journal:  Psychiatry Res       Date:  2002-06-15       Impact factor: 3.222

8.  Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.

Authors:  E Nurmi; J Bergman; O Eskola; O Solin; S M Hinkka; P Sonninen; J O Rinne
Journal:  J Cereb Blood Flow Metab       Date:  2000-11       Impact factor: 6.200

9.  Bupropion occupancy of the dopamine transporter is low during clinical treatment.

Authors:  Jeffrey H Meyer; Verdell S Goulding; Alan A Wilson; Doug Hussey; Bruce K Christensen; Sylvain Houle
Journal:  Psychopharmacology (Berl)       Date:  2002-07-13       Impact factor: 4.530

10.  Metabolism of ( 14 C)methamphetamine in man, the guinea pig and the rat.

Authors:  J Caldwell; L G Dring; R T Williams
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

View more
  75 in total

Review 1.  Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways.

Authors:  Irina N Krasnova; Zuzana Justinova; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2016-02-12       Impact factor: 4.530

2.  Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors.

Authors:  Mary-Lynn Brecht; Diane Herbeck
Journal:  Drug Alcohol Depend       Date:  2014-03-12       Impact factor: 4.492

3.  Increased self-reported impulsivity in methamphetamine users maintaining drug abstinence.

Authors:  Hannah W Jones; Andy C Dean; Kimberly A Price; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2016-07-11       Impact factor: 3.829

4.  Adsorption/desorption and bioavailability of methamphetamine in simulated gastrointestinal fluids under the presence of multiwalled carbon nanotubes.

Authors:  Jing Zhang; Zhenhu Xiong; Lei Wang; Kai Zhang
Journal:  Environ Sci Pollut Res Int       Date:  2015-01-13       Impact factor: 4.223

5.  Predisposition to and effects of methamphetamine use on the adolescent brain.

Authors:  I K Lyoo; S Yoon; T S Kim; S M Lim; Y Choi; J E Kim; J Hwang; H S Jeong; H B Cho; Y A Chung; P F Renshaw
Journal:  Mol Psychiatry       Date:  2015-02-10       Impact factor: 15.992

6.  Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance.

Authors:  Rowan Saloner; Emily W Paolillo; Anya Umlauf; David J Moore; Robert K Heaton; Igor Grant; Mariana Cherner
Journal:  J Int Neuropsychol Soc       Date:  2019-06-10       Impact factor: 2.892

Review 7.  Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies.

Authors:  Milky Kohno; Jeanne Link; Laura E Dennis; Holly McCready; Marilyn Huckans; William F Hoffman; Jennifer M Loftis
Journal:  Pharmacol Biochem Behav       Date:  2019-01-26       Impact factor: 3.533

8.  Ecological momentary assessments for self-monitoring and counseling to optimize methamphetamine treatment and sexual risk reduction outcomes among gay and bisexual men.

Authors:  Cathy J Reback; Dennis Rünger; Jesse B Fletcher; Dallas Swendeman
Journal:  J Subst Abuse Treat       Date:  2018-06-15

9.  Effects of self-administered methamphetamine on discrimination learning and reversal in nonhuman primates.

Authors:  Brian D Kangas; Jack Bergman
Journal:  Psychopharmacology (Berl)       Date:  2016-02       Impact factor: 4.530

10.  Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation.

Authors:  Christopher D Howard; Elissa D Pastuzyn; Melissa L Barker-Haliski; Paul A Garris; Kristen A Keefe
Journal:  J Neurochem       Date:  2013-04-01       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.